share_log

Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $14

Moomoo 24/7 ·  Apr 10 15:27

Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $19 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment